Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma - Wikidata - wikimedia - TriplyDB

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

http://www.wikidata.org/entity/Q28235707

about

High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition βIII-Tubulin: biomarker of taxane resistance or drug target?Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth Microtubules and their role in cellular stress in cancer Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy.Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy.Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.6-Methoxy Podophyllotoxin Induces Apoptosis via Inhibition of TUBB3 and TOPIIA Gene Expressions in 5637 and K562 Cancer Cell Lines.Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.The role of Tau protein in resistance to paclitaxel.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Tubulin: an example of targeted chemotherapy.The Elephant in the Room: The Role of Microtubules in Cancer.High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance

P2860

Q27851983-EB45A81F-B93E-4535-BB2D-46AF59BFE019 Q28071987-1F4C67FC-22D0-4357-8AEE-FB1963F18C7D Q28284878-36945D8A-6D96-4B33-8DFA-B0E394F4982B Q28484303-BC5BB464-59B6-43A9-ABC2-AE3A5F9D0602 Q33770927-75A55457-864B-4C4F-A2F5-1DBED8A3A174 Q34104738-51D97D2D-FED4-463F-9B6B-96CC715F584D Q34266467-D65E0E95-1636-4432-9F65-005677232E75 Q34428153-78994B54-B71C-4055-A2A6-D9EB65B91032 Q34643587-38F558AE-CCB8-414D-A02C-6580F21D43AD Q35214846-06D8811F-590B-4C08-9324-B68E4CB9E6B1 Q35703969-A56894B5-1D90-41AB-B94B-BDE570FFBEF1 Q36080919-826BBDE3-B571-4262-ADF5-156AC25BD82D Q36148796-1543B92F-8EF6-4D6E-8ED4-63E829AFA2A4 Q36608043-B8B1CFA2-5FB5-4DC7-954C-7ABF386D20CC Q37570220-C26656EA-1906-45E2-AE23-819307C127B5 Q37895519-F5C6895F-DB60-479B-AD8A-83BBC5712193 Q37942978-2382D90B-18FA-4607-B347-AF6207AD6722 Q38069185-147E4B09-B2FC-49BD-8D15-FE49798DF80D Q38086872-CD709D5F-D964-4E2C-8FC3-7B5CDFC7D943 Q38672574-DF7A9627-A5CB-42F7-8179-6FC51C6D44A3 Q38770214-34E5993C-5C33-4E21-B55E-B6386D5D7FB9 Q39414846-4204C03F-0765-4302-8A81-D132A3DC5483 Q53681641-C20844FA-D789-4049-9B52-7FAD8CF57EF6 Q58766772-A8A54281-EE9F-4081-857C-392C0BEC69D3

P2860

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

http://www.wikidata.org/entity/Q28235707

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Overexpression of class III be ...... rian clear cell adenocarcinoma

@ast

Overexpression of class III be ...... rian clear cell adenocarcinoma

@en

Overexpression of class III be ...... rian clear cell adenocarcinoma

@nl

type

label

Overexpression of class III be ...... rian clear cell adenocarcinoma

@ast

Overexpression of class III be ...... rian clear cell adenocarcinoma

@en

Overexpression of class III be ...... rian clear cell adenocarcinoma

@nl

prefLabel

Overexpression of class III be ...... rian clear cell adenocarcinoma

@ast

Overexpression of class III be ...... rian clear cell adenocarcinoma

@en

Overexpression of class III be ...... rian clear cell adenocarcinoma

@nl

P1433

Q28235707-05A1A058-9E79-41D4-84BC-A5CCEBB5E374

P1476

Q28235707-0955F87A-4503-45F1-A6D3-4CB258A76227

P2093

Q28235707-03B7750E-1364-43DB-8C81-251DBF6DB912

Q28235707-0FD1D261-0853-4D68-BE7E-DFBE248EADB1

Q28235707-3DD57D38-727E-415B-A09B-E76E5444EDB4

Q28235707-6A704FC3-C4D3-40BB-B778-FB1EFEA63B94

Q28235707-72638AA6-87E9-41CF-B0DD-4BB8A943D792

Q28235707-75C2A5BC-A11E-481B-ABC0-9118647C01DB

Q28235707-87C62C71-439D-4C15-B604-F1F40B4D2A0B

Q28235707-A01F0C25-A973-4E87-8C46-694CE8607C31

Q28235707-AAA60F6B-A994-4145-A535-70E8384DCAE7

Q28235707-D54F653A-0E8B-432E-BC1A-02A9A6E12A4E

P304

Q28235707-B8971EDF-2ED2-4FE3-95C1-A5AF538F2E9A

P31

Q28235707-18F340EA-2A41-4A8D-8B7D-CB36C7C4594C

P3181

Q28235707-15656CEC-0323-4178-BF86-84AA01B1DF5A

P356

Q28235707-4BE57F1F-BC1B-4624-BFAA-64281EAC151D

P407

Q28235707-029F397A-BDF5-4E3A-B052-CC69F38FC212

P433

Q28235707-C25365F9-EAB4-4CAC-BAC4-5CC18AC2BE79

P478

Q28235707-35F332F1-64D4-4B6D-8229-57B1D9B656F2

P50

Q28235707-EC8DD04D-A657-4F5D-9724-37AD8E758F8B

P577

Q28235707-9614E78B-C25F-49E7-A08D-45EBF08421DB

P698

Q28235707-0124D39F-4EA2-48C2-8FE2-E4E0828FD49E

P921

Q28235707-CA6532E1-9E65-47A3-A7CC-9E39B4DDDA4C

Q28235707-DF1E1BF0-8F30-43EA-836C-96E3790FB27F

Q28235707-ECB0B1EE-4175-48E0-89FB-7EE97E5BA457

P3181

P356

1078-0432.CCR-08-1274

P1433

Clinical Cancer Research

P1476

Overexpression of class III be ...... rian clear cell adenocarcinoma

@en

P2093

Ken-ichi Taguchi

http://www.w3.org/2001/XMLSchema#string

Masazumi Tsuneyoshi

http://www.w3.org/2001/XMLSchema#string

Mayumi Ono

http://www.w3.org/2001/XMLSchema#string

Michihiko Kuwano

http://www.w3.org/2001/XMLSchema#string

Nao Suzuki

http://www.w3.org/2001/XMLSchema#string

Satoshi Hattori

http://www.w3.org/2001/XMLSchema#string

Shinji Oie

http://www.w3.org/2001/XMLSchema#string

Suminori Kono

http://www.w3.org/2001/XMLSchema#string

Takashi Yanagawa

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Ohishi

http://www.w3.org/2001/XMLSchema#string

P304

1473-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3930035

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-08-1274

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19228748

http://www.w3.org/2001/XMLSchema#string

P921